Cystic fibrosis: genotypic and phenotypic variations.

Locus Reference Genomic sequences: an improved basis for describing human DNA variants. Genome Med (2010) 4.19

Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet (2001) 3.70

Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest (2008) 3.33

Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A (2006) 2.80

Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol (2004) 2.74

Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet (1999) 2.42

Structure-function analysis of the bestrophin family of anion channels. J Biol Chem (2003) 2.30

Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med (2014) 2.15

TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax (2000) 2.14

Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence. Bioinformatics (2008) 1.85

Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis. Infect Immun (2002) 1.85

Bimodal activation of SMC ATPase by intra- and inter-molecular interactions. EMBO J (2001) 1.78

Airway mucus: From production to secretion. Am J Respir Cell Mol Biol (2006) 1.73

Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion. Physiol Rev (2012) 1.71

Processing and function of CFTR-DeltaF508 are species-dependent. Proc Natl Acad Sci U S A (2007) 1.62

Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax (1998) 1.60

N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J Cell Biol (2009) 1.54

Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut (2003) 1.45

Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis. Infect Immun (1998) 1.45

Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax (2004) 1.43

Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J (2001) 1.40

COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments. J Cell Biol (2001) 1.32

Cooperative assembly and misfolding of CFTR domains in vivo. Mol Biol Cell (2009) 1.31

Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle. Proc Natl Acad Sci U S A (2013) 1.30

Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J Clin Invest (2007) 1.29

Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med (2008) 1.29

Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28

Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. Gastroenterology (2010) 1.27

The role of the UPS in cystic fibrosis. BMC Biochem (2007) 1.26

Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J (1997) 1.26

Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci U S A (2000) 1.26

Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci (2010) 1.25

Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet (2000) 1.23

A Saccharomyces cerevisiae homolog of the human adrenoleukodystrophy transporter is a heterodimer of two half ATP-binding cassette transporters. Proc Natl Acad Sci U S A (1996) 1.22

Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res (2010) 1.20

Regulation of the epithelial sodium channel by accessory proteins. Biochem J (2003) 1.15

Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis. PLoS Genet (2014) 1.14

Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis. Curr Opin Pulm Med (2010) 1.10

Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med (2013) 1.09

Recent advances in cystic fibrosis. Arch Dis Child (2001) 1.08

Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia. Mol Biol Cell (2012) 1.07

A haplotype framework for cystic fibrosis mutations in Iran. J Mol Diagn (2006) 1.05

Value of genetic testing in the management of pancreatitis. Gut (2004) 1.05

Thermally unstable gating of the most common cystic fibrosis mutant channel (ΔF508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops. J Biol Chem (2011) 1.04

The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR. J Physiol (2011) 1.04

Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. J Mol Diagn (2008) 1.03

Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Ther (2009) 1.02

Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol (2007) 1.02

Incorporating personalized gene sequence variants, molecular genetics knowledge, and health knowledge into an EHR prototype based on the Continuity of Care Record standard. J Biomed Inform (2011) 0.98

IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr Pulmonol (2009) 0.98

The search for genetic variants and epigenetics related to asthma. Allergy Asthma Immunol Res (2011) 0.98

Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev (2009) 0.96

State of progress in treating cystic fibrosis respiratory disease. BMC Med (2012) 0.96

A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. Blood (2014) 0.95

Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol Res (2013) 0.93

Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. ScientificWorldJournal (2012) 0.92

From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell (2016) 0.92

Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer (2010) 0.92

Experimental validation of Haldane's hypothesis on the role of infection as an evolutionary force for Metazoans. Proc Natl Acad Sci U S A (2007) 0.92

Exploring the role of integral membrane proteins in ATP-binding cassette transporters: analysis of a collection of MalG insertion mutants. J Bacteriol (1998) 0.91

Insertion and deletion processes in recent human history. PLoS One (2010) 0.91

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates. Front Microbiol (2014) 0.89

Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma. Respir Res (2001) 0.89

A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating. J Physiol (2001) 0.89

IndelFR: a database of indels in protein structures and their flanking regions. Nucleic Acids Res (2011) 0.88

An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening. J Biol Chem (2014) 0.87

New and emerging targeted therapies for cystic fibrosis. BMJ (2016) 0.87

CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR. Br J Pharmacol (2014) 0.86

Gene-Environment Interactions in Asthma: Genetic and Epigenetic Effects. Yonsei Med J (2015) 0.86

Costs, effects, and savings of screening for cystic fibrosis gene carriers. J Epidemiol Community Health (1998) 0.86

CFTR mutations and reproductive outcomes in a population isolate. Hum Genet (2007) 0.86

Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci (2005) 0.85

A candidate-gene association study for berry colour and anthocyanin content in Vitis vinifera L. PLoS One (2012) 0.84

Cystic fibrosis in adults. From researcher to practitioner. West J Med (1996) 0.84

Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator. J Biol Chem (2012) 0.84

The CFTR polymorphisms poly-T, TG-repeats and M470V in Chinese males with congenital bilateral absence of the vas deferens. Asian J Androl (2012) 0.84

Cystic fibrosis chronic rhinosinusitis: a comprehensive review. Am J Rhinol Allergy (2013) 0.83

ClC-5 mutations associated with Dent's disease: a major role of the dimer interface. Pflugers Arch (2011) 0.83

Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis. J Korean Med Sci (2008) 0.82

Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications. Curr Pharm Des (2013) 0.80

FAB-MS characterization of sialyl Lewis x determinants on polylactosamine chains of human airway mucins secreted by patients suffering from cystic fibrosis or chronic bronchitis. Glycoconj J (2001) 0.80

Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and noninterchangeable. Biochim Biophys Acta (2010) 0.80

A single amino acid substitution in CFTR converts ATP to an inhibitory ligand. J Gen Physiol (2014) 0.79

On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator. J Physiol (2016) 0.79

Analysis of CFTR Gene Mutations in Children with Cystic Fibrosis, First Report from North-East of Iran. Iran J Basic Med Sci (2013) 0.79

The molecular genetics of familial intrahepatic cholestasis. Gut (2000) 0.79

The Evolution of Cystic Fibrosis Care. Chest (2015) 0.78

What happens to deltaF508 in vivo? J Clin Invest (1999) 0.78

Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review. Core Evid (2011) 0.78

A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics. J Mol Diagn (2005) 0.78

Common CFTR gene variants influence body composition and survival in rural Ghana. Hum Genet (2009) 0.77

Liver disease in cystic fibrosis: an update. Hepat Mon (2013) 0.77

Development of CFTR Structure. Front Pharmacol (2012) 0.77

Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X. J Med Genet (2007) 0.77

Improvement of chloride transport defect by gonadotropin-releasing hormone (GnRH) in cystic fibrosis epithelial cells. PLoS One (2014) 0.76

Genetics of pancreatitis with a focus on the pancreatic ducts. Minerva Gastroenterol Dietol (2012) 0.76

Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis. Iran Biomed J (2016) 0.75

Synergistic Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Gating by Two Chemically Distinct Potentiators, Ivacaftor (VX-770) and 5-Nitro-2-(3-Phenylpropylamino) Benzoate. Mol Pharmacol (2016) 0.75

Absence of mutations in the interspecies conserved regions of the CFTR promoter region in cystic fibrosis (CF) and CF related patients. J Med Genet (1998) 0.75

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report. J Med Case Rep (2010) 0.75

Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83

Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science (1985) 5.81

Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet (1996) 5.70

A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature (1990) 5.42

A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature (1985) 5.07

The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70

Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60

A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58

Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13

Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70

Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development (1997) 3.66

Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell (1991) 3.56

Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet (1996) 3.50

Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the photoreceptor. Cell (1997) 3.42

Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14

A suggested nomenclature for designating mutations. Hum Mutat (1993) 3.10

Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5. Nucleic Acids Res (2001) 2.89

High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci U S A (1992) 2.72

Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet (1990) 2.72

Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem (1993) 2.69

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65

A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet (1993) 2.64

Introduction and recovery of a selectable bacterial gene from the genome of mammalian cells. Mol Cell Biol (1982) 2.59

A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene (1993) 2.59

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet (1998) 2.51

Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet (1992) 2.48

Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma (1993) 2.38

Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med (1990) 2.37

Characterization of the human beta-crystallin gene Hu beta A3/A1 reveals ancestral relationships among the beta gamma-crystallin superfamily. J Biol Chem (1986) 2.31

Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet (1996) 2.29

Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science (1987) 2.27

Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26

Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A (1998) 2.16

Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 2.07

Methods for analysis of multiple cystic fibrosis mutations. Hum Genet (1991) 1.88

The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet (1999) 1.87

Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast. Cell (1993) 1.72

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70

DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66

Molecular analysis of the PDS gene in Pendred syndrome. Hum Mol Genet (1998) 1.58

CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet (1995) 1.47

Persistence of freely replicating SV40 recombinant molecules carrying a selectable marker in permissive simian cells. Cell (1982) 1.47

An everted repeat mediates retinoic acid induction of the gamma F-crystallin gene: evidence of a direct role for retinoids in lens development. Genes Dev (1993) 1.46

Lung disease in mice with cystic fibrosis. J Clin Invest (1997) 1.44

Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem (1996) 1.41

Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet (1999) 1.41

PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7. Genomics (1997) 1.38

A frameshift mutation in the gamma E-crystallin gene of the Elo mouse. Nat Genet (1992) 1.37

Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37

Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood (1998) 1.36

Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A (1994) 1.34

Identification of genes from a 500-kb region at 7q11.23 that is commonly deleted in Williams syndrome patients. Genomics (1996) 1.33

Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet (1994) 1.32

Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics (1995) 1.32

Genetic analysis of cystic fibrosis using linked DNA markers. Am J Hum Genet (1986) 1.32

A locus for a human hereditary cataract is closely linked to the gamma-crystallin gene family. Proc Natl Acad Sci U S A (1987) 1.31

Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31. Genomics (2001) 1.30

Structural and evolutionary relationships among five members of the human gamma-crystallin gene family. Mol Cell Biol (1985) 1.29

Involvement of the HLXB9 homeobox gene in Currarino syndrome. Am J Hum Genet (2000) 1.29

DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis. Nucleic Acids Res (1989) 1.29

Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet (1995) 1.29

Localization of the gene for X-linked recessive type of retinitis pigmentosa (XLRP) to Xp21 by linkage analysis. Am J Hum Genet (1988) 1.28

Sequence analysis and chromosomal localization of human Cap Z. Conserved residues within the actin-binding domain may link Cap Z to gelsolin/severin and profilin protein families. J Biol Chem (1995) 1.27

Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol Cell Biol (2000) 1.27

Cloning of human genes encoding novel G protein-coupled receptors. Genomics (1994) 1.26

Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26

Cytogenetic rearrangements involving the loss of the Sonic Hedgehog gene at 7q36 cause holoprosencephaly. Hum Genet (1997) 1.25

Lens-specific promoter activity of a mouse gamma-crystallin gene. Mol Cell Biol (1985) 1.24

cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (1991) 1.23

Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet (1992) 1.22

Multiple regulatory elements of the murine gamma 2-crystallin promoter. Nucleic Acids Res (1989) 1.21

Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood (1997) 1.19

Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene (1999) 1.19

Regional localization of 725 human chromosome 7-specific yeast artificial chromosome clones. Genomics (1994) 1.18

Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. JAMA (1999) 1.17

In situ detection of beta-galactosidase in lenses of transgenic mice with a gamma-crystallin/lacZ gene. Science (1987) 1.16

An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J (2000) 1.15

Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem (1991) 1.14

MLK-3: identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domain. Oncogene (1994) 1.14

Study of the expression of myelin proteolipid protein (lipophilin) using a cloned complementary DNA. Nucleic Acids Res (1985) 1.13

Translocation breakpoint maps 5 kb 3' from TWIST in a patient affected with Saethre-Chotzen syndrome. Hum Mol Genet (1997) 1.12

Amplification of CFTR exon 9 sequences to multiple locations in the human genome. Genomics (1997) 1.12

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene (1998) 1.12

A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Am J Hum Genet (1991) 1.11

Mutations in the C-terminal domain of Sonic Hedgehog cause holoprosencephaly. Hum Mol Genet (1997) 1.11

Differential regulation of gamma-crystallin genes during mouse lens development. Dev Biol (1987) 1.11

Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum Mol Genet (1997) 1.09

Assignment of the human gamma-crystallin gene cluster (CRYG) to the long arm of chromosome 2, region q33-36. Hum Genet (1986) 1.09

The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain. Genomics (1995) 1.08

Analysis of the mouse gamma-crystallin gene family: assignment of multiple cDNAs to discrete genomic sequences and characterization of a representative gene. Nucleic Acids Res (1984) 1.08

Screening for genetic mutations. Nature (1996) 1.08

Report of the committee on the genetic constitution of chromosomes 7 and 8. Cytogenet Cell Genet (1989) 1.06

Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp. Oncogene (1994) 1.06

Mapping of the cystic fibrosis locus on chromosome 7. Cold Spring Harb Symp Quant Biol (1986) 1.06

Isolation of three novel human genes encoding G protein-coupled receptors. DNA Cell Biol (1995) 1.05

Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family. Mol Cell Biol (1987) 1.05

Regulation of meiotic chromatin loop size by chromosomal position. Proc Natl Acad Sci U S A (1996) 1.04

Relationship between proteins encoded by three human gamma-crystallin genes and distinct polypeptides in the eye lens. Mol Cell Biol (1987) 1.04